Roxro Files Rapid-acting Nasal Pain Spray
This article was originally published in The Pink Sheet Daily
Specialty pharma reinvents generic ketorolac as hospital-strength pain med for short-term use at home.
You may also be interested in...
Journal ad for the ophthalmic misleadingly suggests the drug is indicated for phacoemulsification, according to FDA.
Bristol will cease distribution of the antidepressant Serzone (nefazodone) effective June 14
Part 2: High costs are built into the rare disease business model. Participants at a roundtable discussion led by Scrip at the J.P. Morgan Healthcare Conference talked about how much they are feeling the pressure on pricing.